IL17A and breast cancer: While IL-17/IL-23 in psoriasis drives immune cell activation, leading to chronic skin inflammation, this same pathway has been implicated in breast cancer, as IL-17 contributes to tumor growth and metastasis by attracting immune cells that support tumor expansion.